CHRU de Poitiers La Miletrie

Poitiers 90577

1 studies enrolling now · 7 studies all time

What they study most

AML Arising From Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Cytomegalovirus (CMV), Leukemia, Myeloid, Acute, Macular Edema, Metastatic Non Small Cell Lung Cancer, Multiple Myeloma, Newly Diagnosed Acute Myeloid Leukemia (AML), Relapsed and/or Refractory Multiple Myeloma, Retinal Vein Occlusion, Untreated AML

Studies at this site

• Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer — Recruiting now
• Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation — Running, not enrolling
• A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy — Completed
• An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants — Stopped early
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) — Completed
• A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma — Completed
• Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir — Completed